US Patent 7915273 Compositions and methods for inhibition of the JAK pathway

Patent 7915273 was granted and assigned to Rigel Pharmaceuticals on March, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Rigel Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7915273

Date of Patent

March 29, 2011

Patent Application Number

12711534

Date Filed

February 24, 2010

Patent Citations Received

‌

US Patent 11667611 Compositions and methods for inhibition of the JAK pathway

Patent Primary Examiner

‌

Deepak Rao

Patent abstract

The invention encompasses compounds having formula I and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, are therapeutically useful.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7915273 Compositions and methods for inhibition of the JAK pathway

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API